Chimerix Inc logo

Chimerix Inc Share Price Today (NASDAQ: CMRX)

Chimerix Inc share price is $0 & ₹0.00 as on 16 Apr 2025 IST

▲

-8.54

(-100%)

Market is closed - opens 7 PM, 17 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 17 Apr 2025

View live Chimerix Inc share price in Dollar and Rupees. Guide to invest in Chimerix Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Chimerix Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Chimerix Inc (CMRX) Key Statistics

in dollars & INR

Previous Close
$8.54
Open
$8.55
Market Capitalization
$801.1M
Today's Volume
$755.4K
Revenue TTM
$212.0K
EBITDA
$-96.5M
Earnings Per Share (EPS)
$-0.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-56.17%

How to invest in Chimerix Inc Stock (CMRX) from India?

It is very easy for Indian residents to invest directly in Chimerix Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chimerix Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Chimerix Inc or CMRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chimerix Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chimerix Inc shares which would translate to null fractional shares of Chimerix Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Chimerix Inc, in just a few clicks!

Global Institutional Holdings in Chimerix Inc

  • RA Capital Management, LLC

    9.46%

  • Vanguard Group Inc

    4.35%

  • Deerfield Management Co

    4.05%

  • Rosalind Advisors, Inc.

    3.28%

  • Monaco Asset Management

    3.03%

  • Millennium Management LLC

    2.75%

Analyst Recommendation on Chimerix Inc

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Chimerix Inc(by analysts ranked 0 to 5 stars)

About Chimerix Inc

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases in the United States. Its product pipeline comprising dordaviprone (ONC201), which is in phase 3 clinical-stage development for H3 K27M-mutant diffuse glioma, as well as in phase 2 Investigator Initiated Clinical Trials for multiple oncology studies; and ONC206, a second generation imipridone ClpP agonist and DRD2 antagonist which is in phase 1 clinical trial to treat central nervous systems and other solid tumors. The company also develops ONC212, an imipridone, investigational agonist of the orphan GPCR tumor suppressor GPR132, as well as ClpP, which is in preclinical trial; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of novel coronaviruses. In addition, it offers TEMBEXA, a lipid conjugate which acts via inhibition of viral DNA synthesis that is a medical countermeasure for smallpox. The company has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.
Organization
Chimerix Inc
Employees
79
CEO
Mr. Michael T. Andriole M.B.A.
Industry
Health Technology

Management People of Chimerix Inc

NameTitle
Mr. Michael T. Andriole M.B.A.
CEO, President & Director
Dr. Michael A. Alrutz J.D., Ph.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Allen S. Melemed M.B.A., M.D.
Chief Medical Officer
Ms. Michelle LaSpaluto
Chief Financial Officer
Mr. Thomas J. Riga
Chief Operating & Commercial Officer
Dr. Roy W. Ware M.B.A., Ph.D.
Chief Manufacturing & Technology Officer
Dr. Joshua E. Allen Ph.D.
Chief Scientific Officer

Important FAQs about investing in CMRX Stock from India :

Can Indians buy Chimerix Inc shares?

Yes, Indians can invest in the Chimerix Inc (CMRX) from India.

With INDmoney, you can buy Chimerix Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Chimerix Inc at zero transaction cost.

How can I buy Chimerix Inc shares from India?

It is very easy to buy Chimerix Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Chimerix Inc (CMRX) be purchased?

Yes, you can buy fractional shares of Chimerix Inc with INDmoney app.

What are the documents required to start investing in Chimerix Inc stocks?

To start investing in Chimerix Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Chimerix Inc?

Today's market capitalisation of Chimerix Inc CMRX is 801.1M

Who is the Chief Executive Officer (CEO) of Chimerix Inc ?

Mr. Michael T. Andriole M.B.A. is the current Chief Executive Officer (CEO) of Chimerix Inc.